Ngam Advisors L.P. Purchases 9,236 Shares of Aetna Inc. (AET)
Ngam Advisors L.P. boosted its position in Aetna Inc. (NYSE:AET) by 15.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,735 shares of the company’s stock after buying an additional 9,236 shares during the period. Ngam Advisors L.P.’s holdings in Aetna were worth $7,935,000 as of its most recent filing with the SEC.
Other hedge funds have also recently added to or reduced their stakes in the company. PGGM Investments boosted its stake in Aetna by 54.7% in the second quarter. PGGM Investments now owns 794,893 shares of the company’s stock worth $97,080,000 after buying an additional 280,978 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in Aetna by 4.1% in the second quarter. Nisa Investment Advisors LLC now owns 145,191 shares of the company’s stock worth $17,732,000 after buying an additional 5,750 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its stake in Aetna by 24.9% in the third quarter. Oregon Public Employees Retirement Fund now owns 90,652 shares of the company’s stock worth $10,466,000 after buying an additional 18,063 shares in the last quarter. Retirement Systems of Alabama boosted its stake in Aetna by 0.3% in the second quarter. Retirement Systems of Alabama now owns 178,739 shares of the company’s stock worth $21,829,000 after buying an additional 600 shares in the last quarter. Finally, Macquarie Group Ltd. boosted its stake in Aetna by 5.8% in the second quarter. Macquarie Group Ltd. now owns 175,079 shares of the company’s stock worth $21,382,000 after buying an additional 9,547 shares in the last quarter. Institutional investors own 88.28% of the company’s stock.
Shares of Aetna Inc. (NYSE:AET) traded down 0.887% during midday trading on Wednesday, hitting $130.859. The company had a trading volume of 1,422,772 shares. The company has a 50-day moving average of $115.34 and a 200-day moving average of $116.60. The company has a market capitalization of $45.92 billion, a PE ratio of 18.872 and a beta of 0.54. Aetna Inc. has a 12 month low of $92.42 and a 12 month high of $132.36.
Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, October 27th. The company reported $2.07 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.02 by $0.05. Aetna had a return on equity of 16.25% and a net margin of 3.91%. The company earned $15.78 billion during the quarter, compared to analyst estimates of $15.71 billion. During the same period in the previous year, the business earned $1.90 EPS. Aetna’s quarterly revenue was up 5.5% on a year-over-year basis. Analysts predict that Aetna Inc. will post $8.02 earnings per share for the current year.
WARNING: This piece of content was first reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright and trademark law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2016/11/30/ngam-advisors-l-p-purchases-9236-shares-of-aetna-inc-aet.html.
A number of brokerages have recently issued reports on AET. Zacks Investment Research raised Aetna from a “sell” rating to a “hold” rating in a report on Tuesday, November 22nd. FBR & Co reissued a “hold” rating on shares of Aetna in a report on Wednesday, August 17th. Credit Suisse Group AG reaffirmed a “hold” rating and issued a $120.00 price objective on shares of Aetna in a research note on Wednesday, August 17th. Jefferies Group reaffirmed a “hold” rating on shares of Aetna in a research note on Tuesday, August 23rd. Finally, Sanford C. Bernstein downgraded Aetna from an “outperform” rating to a “market perform” rating and set a $132.00 price objective on the stock. in a research note on Monday, November 14th. Seven research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $132.14.
In other Aetna news, Director Jeffrey E. Garten sold 7,100 shares of the business’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total transaction of $827,221.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.